Obesity defined as excess storage of inert triglycerides - Do we need a paradigm shift?

Obesity Facts

Volumn 4, Issue 2, 2011, Pages 91-94

  Sørensen, Thorkild I A ^a  

^a The Capital Region   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

TRIACYLGLYCEROL;

BIOACCUMULATION; BODY FAT; BODY FAT DISTRIBUTION; BODY MASS; CARDIOVASCULAR DISEASE; CEREBROVASCULAR DISEASE; COMORBIDITY; CORRELATION ANALYSIS; DIABETES MELLITUS; DIETARY INTAKE; HEALTH HAZARD; HIGH RISK POPULATION; HUMAN; LIPID STORAGE; NOMENCLATURE; OBESITY; PRIORITY JOURNAL; REVIEW; RISK FACTOR;

ADIPOSE TISSUE; HUMANS; OBESITY; TRIGLYCERIDES;

EID: 79956067249     PISSN: 16624025     EISSN: 16624033     Source Type: Journal    
DOI: 10.1159/000328198     Document Type: Review

References (17)

1. Sørensen TIA, Virtue A, Vidal-Puig A: Obesity as a clinical and public health problem: is there a need for a new definition based on lipotoxicity effects? Biochem Biophys Acta 2010;1801:400-404.
2. Tan CY, Vidal-Puig A: Adipose tissue expandability: the metabolic problems of obesity may arise from inability to become more obese. Biochem Soc Trans 2008;36:935-940.
3. Virtue S, Vidal-Puig A: Adipose tissue expandability, lipotoxicity and the metabolic syndrome - an allostatic perspective. Biochim Biophys Acta 2010;1801:338-349.
4. Gonzales ABD, Hartge P, Cerhan JR, Flint AJ, Hannan L, MacInnis RJ, et al: Body-mass index and mortality among 1.46 millions white adults. N Engl J Med 2010;363:2211-2219.
5. The Emerging Risk Factors Collaboration: Separate and combined associations of body-mass index and abdominal adiposity with cardiovascular disease: collaborative analysis of 58 prospective studies. Lancet 2011;377:1085-1095.
6. Bigaard J, Frederiksen K, Tjønneland A, Thomsen BL, Overvad K, Heitmann BL, Sørensen TIA: Body fat and fat-free mass and all-cause mortality. Obes Res 2004;12:1042-1049. (Pubitemid 41132482)
7. Stegger JG, Schmidt EB, Obel T, Berentzen TL, Tjønneland A, Sørensen TIA, Overvad K: Body composition and body fat distribution in relation to later risk of acute myocardial infarction: a Danish follow-up study. Int J Obes (Lond) 2011; doi:10.1038/ijo.2010.278.
8. Zimmermann E, Holst C, Sørensen TIA: Lifelong doubling of mortality in men entering adult life as obese. Int J Obes (Lond) 2011; doi:10.1038/ijo.2010.274.
9. Bigaard J, Frederiksen K, Tjønneland A, Thomsen BL, Overvad K, Heitmann BL, Sørensen TIA: Waist circumference and body composition in relation to all-cause mortality in middle-aged men and women. Int J Obes (Lond) 2005;29:778-784. (Pubitemid 40897014)
10. Kotronen A, Yki-Järvinen H, Sevastianova K, Bergholm R, Hakkarainen A, Pietiläinen KH, Juurinen L, Lundbom N, Sørensen TIA: Comparison of the relative contributions of intra-abdominal and liver fat to components of the metabolic syndrome. Obesity (Silver Spring). 2011;19:23-28.
11. Jakobsen MU, Berentzen T, Sørensen TIA, Overvad K: Abdominal obesity and fatty liver. Epidemiol Rev 2007;29:77-87. (Pubitemid 47229638)
12. Speliotes EK, Butler JL, Palmer CD, Voight BF; GIANT Consortium; MIGen Consortium; NASH CRN, Hirschhorn JN: PNPLA3 variants specifically confer increased risk for histologic nonalcoholic fatty liver disease but not metabolic disease. Hepatology 2010;52:904-912.
13. Sørensen TIA: Challenges in the study of causation of obesity. Proc Nutr Soc 2009;68:43-54.
14. Flatt JP: Issues and misconceptions about obesity. Obesity 2011;19:676-686.
15. Vidal-Puig A, Unger R: Special issue on lipotoxicity. Biochim Biophys Acta 2010;1801:207-208.
16. DeFronzo RA, Tripathy D, Schwenke DC, Barnerji MA, Bray GA, Buchanan TA, et al: Pioglitazone for diabetes prevention in impaired glucose tolerance. N Engl J Med 2011;364:1104-1115.
17. Berentzen T, Sørensen TIA: Effects of intended weight loss on morbidity and mortality: possible explanations of controversial results. Nutr Rev 2006;64:502-507. (Pubitemid 44808266)